Thermogenesis Expects PMA Approval For CryoSeal Sealant By Year’s End
This article was originally published in The Gray Sheet
Executive Summary
Thermogenesis plans to market its CryoSeal FS fibrin sealant system to large surgery hospitals immediately upon FDA approval, expected in late 2006
You may also be interested in...
Stem Cell Therapy Needs More Than Just The Cells: Device Firms See Opening
The advent of stem cell therapy to future medicine will be facilitated by medical devices that actually process and store the cells. At least two firms already see near-term opportunities to pioneer the technology
US FDA Drugs Center Ready To Break Down Silos On Regulatory Innovation
CDER Director Cavazzoni is promising to increase coordination and collaboration to accelerate broader adoption of innovative clinical trial designs and other approaches to speed drug development. A new "Quantitative Medicine Center of Excellence" illustrates the approach.